TIAA CREF INVESTMENT MANAGEMENT LLC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 141 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$2,289,000
+461.0%
773,231
+201.4%
0.00%
Q4 2018$408,000
-80.5%
256,529
-54.8%
0.00%
-100.0%
Q3 2018$2,088,000
+18.6%
567,380
-8.8%
0.00%0.0%
Q2 2018$1,760,000
-40.4%
621,860
-21.9%
0.00%
-50.0%
Q1 2018$2,955,000
+182.2%
796,389
+119.0%
0.00%
+100.0%
Q4 2017$1,047,000
-27.4%
363,571
+13.2%
0.00%0.0%
Q3 2017$1,442,000
-26.8%
321,213
-25.1%
0.00%0.0%
Q2 2017$1,969,000
+14.7%
428,933
+5.2%
0.00%0.0%
Q1 2017$1,717,000
+4.7%
407,750
+2.7%
0.00%0.0%
Q4 2016$1,640,000
-59.5%
397,192
-20.5%
0.00%
-66.7%
Q3 2016$4,049,000
+7.6%
499,828
+3.6%
0.00%0.0%
Q2 2016$3,764,000
-7.1%
482,512
-8.1%
0.00%0.0%
Q1 2016$4,053,000
-35.2%
524,991
-9.5%
0.00%
-40.0%
Q4 2015$6,257,000
+89.4%
579,919
+21.3%
0.01%
+66.7%
Q3 2015$3,304,000
-28.5%
478,105
-8.3%
0.00%0.0%
Q2 2015$4,620,000
-2.4%
521,428
+8.6%
0.00%0.0%
Q1 2015$4,733,000
-10.5%
480,007
+11.2%
0.00%
-25.0%
Q4 2014$5,289,000
+17.3%
431,781
-4.4%
0.00%
+33.3%
Q3 2014$4,509,000
+34.3%
451,833
+1.9%
0.00%
+50.0%
Q2 2014$3,357,000
+151.3%
443,495
+9.2%
0.00%
+100.0%
Q1 2014$1,336,000
-3.1%
405,954
-2.3%
0.00%0.0%
Q4 2013$1,379,000
+18.3%
415,484
+7.6%
0.00%0.0%
Q3 2013$1,166,000
-64.5%
385,984
-3.9%
0.00%
-66.7%
Q2 2013$3,284,000401,5030.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q4 2016
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders